Bli medlem
Bli medlem

Du är här


Nuevolution: Replay of two investor presentations available

Stockholm, 20 May 2016. Nuevolution's Chief Executive Officer, Alex
Haahr Gouliaev, provided an overview of the company, and gave an
update on the company's pipeline programs and partnering activities
at Avanza Bank's Börsdag in Stockholm and at Aktiespararna's Aktiedag
in Gothenburg in Wednesday 18 May.

A replay of the presentation (in English) in Stockholm can be found

A replay of the presentation (in English, but Q&A in Swedish and
English) in Gothenburg can be found on:

For more information, please contact:

Alex Haahr Gouliaev, CEO

Phone: +45 7020 0987


Henrik D. Simonsen, CFO

Phone: +45 3913 0947


About Nuevolution

Nuevolution AB (publ) is a leading small molecule drug discovery
biotech company founded in 2001, headquartered in Copenhagen,
Denmark. Nuevolution partners its proprietary discovery platform and
programs with pharmaceutical and biotechnology companies to seek
future benefit of patients in need of novel medical treatment
options. Nuevolution's internal programs are focused on
therapeutically important targets within inflammation, oncology and

Nuevolution AB (publ) is required to disclose the information provided
herein pursuant to the Securities Markets Act and/or the Financial
Instruments Trading Act. The information was sent for publication on
Friday 20 May 2016, 12:00 (CET).

Nuevolution AB (publ) is listed at Nasdaq First North Premier in
Stockholm, Sweden (ticker: NUE). Västra Hamnen Corporate Finance AB
acts as Certified Adviser to Nuevolution AB (publ). More information
about Nuevolution can be found on:


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.